EAM
Exome Asset Management Portfolio holdings
AUM
$170M
1-Year Est. Return
208.51%
This Fund
S&P 500
1 Year Est. Return
+208.51%
AUM
$202M
AUM Growth
+$51M
(+34%)
Holding
82
Top Buys
| 1 | +$5.81M | |
| 2 | +$4.8M | |
| 3 | +$4.43M | |
| 4 |
Wave Life Sciences
WVE
|
+$4.28M |
| 5 |
Jazz Pharmaceuticals
JAZZ
|
+$4.06M |
Top Sells
| 1 | +$8.17M | |
| 2 | +$4.16M | |
| 3 | +$4.02M | |
| 4 |
Cogent Biosciences
COGT
|
+$3.88M |
| 5 |
Apogee Therapeutics
APGE
|
+$3.75M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SLNO
76
DELISTED
Soleno Therapeutics
SLNO
| – | – |
-48,445
|
|
||
77
Syndax Pharmaceuticals
SNDX
$1.54B
| – | – |
-117,783
|
|
||
|
VTYX
78
DELISTED
Ventyx Biosciences
VTYX
| – | – |
-60,600
|
|
||
|
ATYR
79
aTyr Pharma
ATYR
$46.1M
| – | – |
0
|
|
||
|
MBX
80
MBX Biosciences
MBX
$1.44B
| – | – |
-52,402
|
|